GlassScriptPhysician profile
Blake William Perkins
NPI 1760827273
$1,699.49
in general payments reported to CMS, 2019-2025
10 companies · $58.14 in 2025
The $58.14 reported for 2025 was less than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $36.76 · 2021: $34.06 · 2022: $60.67 · 2023: $259 · 2024: $1,251 · 2025: $58.14.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $995 · Food and Beverage: $573.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $995.48 |
| Food and Beverage | $572.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $995.48 | 2024 | Carto 3 |
| W. L. Gore & Associates, INC. | $233.48 | 2023-2025 | Gore Tag Thoracic Branch Endoprosthesis, Gore Tag Conformable Thoracic Stent Graft, Excluder Conformable Aaa Endoprosthesis With Active Control |
| Atricure, INC. | $141.81 | 2024 | |
| Edwards Lifesciences Corporation | $89.76 | 2023 | Hemosphere |
| Terumo Medical Corporation | $81.65 | 2021-2022 | |
| Biosense Webster, INC. | $81.22 | 2024 | Carto 3 |
| Boston Scientific Corporation | $26.25 | 2025 | General - Therapies |
| Covidien LP | $19.08 | 2019 | |
| Mallinckrodt Enterprises LLC | $17.68 | 2019 | |
| Merck Sharp & Dohme LLC | $13.08 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Blake Perkins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.